A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor
about
G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroidsStructure of an agonist-bound human A2A adenosine receptorRole of glycosphingolipids in the function of human serotonin₁A receptorsInternal lipid architecture of the hetero-oligomeric cytochrome b6f complexThe structural basis for agonist and partial agonist action on a β(1)-adrenergic receptorStructure of a nanobody-stabilized active state of the β(2) adrenoceptorStructures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonistsIdentification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observationsThe 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonistThe Use of Multiscale Molecular Simulations in Understanding a Relationship between the Structure and Function of Biological Systems of the Brain: The Application to Monoamine Oxidase EnzymesDiversity and modularity of G protein-coupled receptor structuresLarge-scale production and protein engineering of G protein-coupled receptors for structural studiesNew insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptorsTurning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentCUP-1 is a novel protein involved in dietary cholesterol uptake in Caenorhabditis elegansEndogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments.Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-associationMembrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCRInduced effects of sodium ions on dopaminergic G-protein coupled receptorsLigand-specific regulation of the extracellular surface of a G-protein-coupled receptorConserved Binding Mode of Human β 2 Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray CrystallographyStructure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective AntagonistTwo distinct conformations of helix 6 observed in antagonist-bound structures of a 1-adrenergic receptorHigh Resolution Structure of the ba3 Cytochrome c Oxidase from Thermus thermophilus in a Lipidic EnvironmentTowards protein-crystal centering using second-harmonic generation (SHG) microscopyCrystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and CarvedilolLipidic cubic phase injector facilitates membrane protein serial femtosecond crystallographyThe 2.1 Å Resolution Structure of Cyanopindolol-Bound β1-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free ReceptorStructural basis for Smoothened receptor modulation and chemoresistance to anticancer drugsUnderstanding functional residues of the cannabinoid CB1.There Is No Simple Model of the Plasma Membrane OrganizationMembrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR FunctionA predicted binding site for cholesterol on the GABAA receptorFunction-specific virtual screening for GPCR ligands using a combined scoring methodRecombinant human melatonin receptor MT1 isolated in mixed detergents shows pharmacology similar to that in mammalian cell membranesConformational antibody binding to a native, cell-free expressed GPCR in block copolymer membranes3D structure prediction of human β1-adrenergic receptor via threading-based homology modeling for implications in structure-based drug designingModulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipidThe Principles of Ligand Specificity on beta-2-adrenergic receptorThe biology of CCR5 and CXCR4
P2860
Q22305605-385CD49D-F0EC-48D1-B18D-3E5598546D6FQ24296388-BB8C5C1A-B7DD-4B16-8718-665361BA033EQ24298268-46A4FEFE-8A49-4436-81F2-B6CF7523330AQ24561993-3741C101-7261-44BE-B66D-4379833A4500Q24594844-A1713660-A1A2-4A3C-A20E-AB23433350A4Q24597139-D366F608-18E8-43E5-AF00-61DE9C562CD1Q24619974-28CFE83E-F42B-4B98-8E36-910A4AB51D4BQ24645752-881CFF2D-ADC5-4BA3-897F-FF42C8004005Q24654563-89819F80-DD02-4940-AEA4-4465D5348D99Q26740761-C271CE7B-8EB9-4514-B17B-8913A5F6FE38Q26852976-BC44A97E-98FC-4D5E-834B-B11BF79AF346Q26866010-DA152FF8-433E-47A9-AB2B-F7E6DDB852DFQ26991761-6F3430E9-FA50-4366-B510-64CFBE54069EQ27024397-7716BF7B-DB8F-41E7-A9F0-4E339BB5BE56Q27305927-CFED6F98-D7C0-496E-BC12-C2B329FEE53BQ27308091-BAAE4A68-01A1-4859-9CBB-42A1D7E8B241Q27319797-CBA36816-2B35-4772-8A41-302AF2D98413Q27329683-1E6D985C-6486-4660-B05B-9EE597DFDEF6Q27334712-E3881744-9E2E-4461-ADA7-1FFFBB936FC5Q27646733-C840EC52-A13B-4FF3-B87E-2CD63E4146DAQ27663654-8F8570AD-1EBF-4C0E-9949-95CD4BBDBEF3Q27666030-BBF5528D-95AD-4059-8E53-E2AAFDDC2E09Q27667675-84BE52C2-CAC9-4F91-89E1-7F4C45F2B0FCQ27671514-D57DE099-87E2-4593-B2BD-1FDF29C5EE2CQ27677940-8CF6A4F2-1C7C-4AB7-81FD-95B5B484FCE5Q27679036-05E5D113-A7D6-43AD-96ED-932809413805Q27681713-54AA9C21-5D99-4F25-AEDB-B43618444F80Q27682443-FAFCC838-2C81-4340-AD0C-54426696FC2EQ27684635-60D34A61-9D1B-4982-BE8A-6636DC90E613Q27687653-B23AE69D-3DB9-4ADC-A2D8-92D5247AB65AQ28067186-DF928089-023E-4250-B6C8-7F7F7DA1842FQ28072820-851440CA-878E-4DE8-8C89-3DC3D5BC2889Q28239688-12CE1459-8239-4C4B-B885-D61752E2ED20Q28276613-90575146-9AA2-4640-B027-158EAF0C26F8Q28539972-4F2AD419-06C8-46F3-AF68-EDFC328065C9Q28543955-6EF1794D-9CBC-4EAA-ADBC-BDBA92F08345Q28546076-800BA61D-01C2-40FA-8D96-F45E297BD028Q28584277-CE725B21-920D-4F5B-9A53-3D451E6FDADEQ28822521-C2434B57-FA96-4291-B890-316ECA53E058Q29012920-AD0980D0-F600-4087-8128-B9D7C1DA8F6B
P2860
A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@ast
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@en
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@nl
type
label
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@ast
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@en
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@nl
prefLabel
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@ast
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@en
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@nl
P2093
P2860
P50
P3181
P1433
P1476
A Specific Cholesterol Binding ...... e Human β2-Adrenergic Receptor
@en
P2093
Christopher B Roth
Ellen Y T Chien
Jeffrey Velasquez
Mark T Griffith
Michael A Hanson
Peter Kuhn
P2860
P304
P3181
P356
10.1016/J.STR.2008.05.001
P577
2008-06-01T00:00:00Z